CD40 and pancreatic neoplasm: The assessment of CD40 expression on the surface of pancreatic cancer cells revealed that at stage I of the disease, the cells were CD40-negative, whereas in patients with lymph node involvement and distant metastases, the cells exhibited high expression of CD40.